glp-1 gi obstruction lawsuit in west virginia Ozempic Lawsuits kentucky semaglutide stomach paralysis law

National Union Fire Insurance Co

Dosing Protocol Key Efficacy Data The SURMOUNT clinical trial program established tirzepatide as the most effective GLP-1 weight loss agent currently available: SURMOUNT-1 (adults without diabetes): Mean weight loss of 20.9% (10 mg), 24.0% (15 mg) at 72 weeks versus 3.1% placebo (Jastreboff et al., NEJM , 2022) SURMOUNT-2 (adults with type 2 diabetes): Mean weight loss of 12.8% (10 mg), 14.7% (15 mg) at 72 weeks (Garvey et al., Lancet , 2023) SURMOUNT-3 (after intensive lifestyle intervention lead-in): Mean total weight loss of 26.6% with tirzepatide 15 mg (Wadden et al., Nature Medicine , 2023) SURMOUNT-4 (withdrawal study): Patients who discontinued tirzepatide after 36 weeks regained approximately two-thirds of lost weight by week 88, demonstrating the chronic disease nature of obesity and the need for ongoing treatment (Aronne et al., JAMA , 2024) Why Dual Agonism Matters The GIP receptor activation in tirzepatide produces additive effects beyond GLP-1 agonism alone

primary-cta Is Orlistat Worth the Cost

I really was not expecting to review this product so soon after getting it